AI주식인사이트AI Stock Insight
B

바이오플러스

099430KOSDAQ

55.5 / 100

Reference Date: 2026-10-23

Financial Score26.0 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Rose 6.6% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

BioPlus is a company specializing in the development and sale of medical devices, bio-pharmaceuticals, and bio-cosmetics, leveraging technologies such as MDM and temperature-sensitive materials to enhance product performance. To expand globally, the company has established a foreign subsidiary in Hainan, China, and operates a large-scale factory in Chungcheongbuk, South Korea, focusing on improving profitability.

Number of Employees

187people

Average Salary

60.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
13.74Industry Average 15.005.0Point

In line with industry avg

PBR
1.10Industry Average 1.204.0Point

In line with industry avg

ROE
11.67Industry Average 8.004.0Point

In line with industry avg

Debt Ratio
6.54Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲19.5% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼26.1% (2-year basis)

ROE Trend
2.5 / 4

Avg ROE 15.2% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 3,475Won52-week high 6,46052-week low 3,210
1-month return4.0Point

1m +6.60% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-10-08